Godsey & Gibb Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.43K | Sell |
49
-117
| -70% | -$8.18K | ﹤0.01% | 307 |
|
2025
Q1 | $12.2K | Buy |
166
+117
| +239% | +$8.6K | ﹤0.01% | 267 |
|
2024
Q4 | $3.21K | Hold |
49
| – | – | ﹤0.01% | 324 |
|
2024
Q3 | $3.82K | Sell |
49
-178
| -78% | -$13.9K | ﹤0.01% | 378 |
|
2024
Q2 | $17.7K | Sell |
227
-6
| -3% | -$468 | ﹤0.01% | 260 |
|
2024
Q1 | $15.8K | Sell |
233
-522
| -69% | -$35.4K | ﹤0.01% | 241 |
|
2023
Q4 | $50.9K | Hold |
755
| – | – | 0.01% | 161 |
|
2023
Q3 | $51.1K | Sell |
755
-30
| -4% | -$2.03K | 0.01% | 155 |
|
2023
Q2 | $56.2K | Hold |
785
| – | – | 0.01% | 158 |
|
2023
Q1 | $54.5K | Sell |
785
-200
| -20% | -$13.9K | 0.01% | 161 |
|
2022
Q4 | $66.8K | Sell |
985
-248
| -20% | -$16.8K | 0.01% | 100 |
|
2022
Q3 | $68K | Buy |
+1,233
| New | +$68K | 0.05% | 27 |
|